Liquid Biopsy to Detect Minimal Residual Disease: Methodology and Impact

Volume: 13, Issue: 21, Pages: 5364 - 5364
Published: Oct 26, 2021
Abstract
One reason why some patients experience recurrent disease after a curative-intent treatment might be the persistence of residual tumor cells, called minimal residual disease (MRD). MRD cannot be identified by standard radiological exams or clinical evaluation. Tumor-specific alterations found in the blood indirectly diagnose the presence of MRD. Liquid biopsies thus have the potential to detect MRD, allowing, among other things, the detection of...
Paper Details
Title
Liquid Biopsy to Detect Minimal Residual Disease: Methodology and Impact
Published Date
Oct 26, 2021
Journal
Volume
13
Issue
21
Pages
5364 - 5364
Citation AnalysisPro
  • Scinapse’s Top 10 Citation Journals & Affiliations graph reveals the quality and authenticity of citations received by a paper.
  • Discover whether citations have been inflated due to self-citations, or if citations include institutional bias.